- GSK -1.34%
Search results
- 43.19Add to watchlist-0.58 (-1.34%)As of Thu. Sep 12, 2024 1:08 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open43.43High43.48Low43.13
- Mkt Cap88.07BP/E (TTM)14.64Div & Yield1.53 & 3.50%
- Prev. Close43.7752 Wk. Low33.6752 Wk. High45.93
What analysts are sayingTop storiesGSK’s Phase I/II herpes simplex vaccine trial misses primary endpointYahoo Finance · 8 hours ago- GSK -1.34%
GSK reports results from Phase III trials of drug candidate for severe asthmaYahoo Finance · 2 days agoGSK’s asthma blockbuster Nucala secures win in COPD Phase III trialYahoo Finance · 6 days agoRelated stocks
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London.
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
Home | GSK US. We are taking "Five for Five" this September. We are launching "Five for Five," an initiative designed to raise awareness about gynecological cancers during Gynecologic and Ovarian Cancer Awareness Month. Learn more about Five for Five. Behind the science US edition. Thinking outside the box: a personal journey.
Meet our people. We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
From quarterly updates to key announcements, here you can access GSK investor-related information.
Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.